Milestones :: Perspectives :: Research
DRC – Ebola/Cholera/Measles
Disease Outbreak News (DONs)
Ebola virus disease – Democratic Republic of the Congo
6 June 2019
As the Ebola virus disease (EVD) outbreak surpasses the 2000 case mark, indicators over the past two weeks provide early signs of an easing of the transmission intensity. This follows a period of improved security and therefore access to communities, allowing response teams to operate more freely…
44: Situation report on the Ebola outbreak in North Kivu
4 June 2019
…Implementation of ring vaccination protocol
:: As of 1 June 2019, 129,001 people at risk have consented to and received the rVSV-ZEBOV-GP Ebola vaccine. Of those, 33 046 are contacts and 87 886 contacts-of-contacts. The total number of vaccines includes 31,016 HCWs/FLWs and 34,522 children 1-17 years of age.
:: Six new rings (2 in Butembo and 2 in Katwa) have opened around eight out of the 12 confirmed cases from 1 June 2019.
:: Despite the challenges in the field and considering the cases reported between 30 April 2019 and 20 May 2019, only 31/337 (9.2%) of the cases do not have a ring defined and their contacts and contacts-of-contacts vaccinated. For 113/337 (33.5%) of the cases the ring vaccination was completed and for 193/337 (57.2%) ring vaccination was ongoing at the time of writing this report. This important progress is the result of the use of innovative delivery strategies (i.e. pop-up vaccination and targeted geographic vaccination) and strong community negotiations and engagement.
CDC director expects to run out of Ebola vaccine
Devex, by Michael Igoe // 06 June 2019
WASHINGTON — The director of the Centers for Disease Control and Prevention predicts that responders in the Democratic Republic of the Congo will exhaust the current supply of the Ebola virus vaccine before the pharmaceutical company manufacturing them can produce more.
Robert Redfield, director at CDC, relayed that warning to U.S. lawmakers on Tuesday, just as new reports indicated the number of Ebola virus cases in eastern DRC has climbed past 2,000. While the Ebola vaccine has been helpful in this unprecedentedly difficult response effort, regulatory delays have stalled production of new vaccine stocks, Redfield said in a U.S. House of Representatives hearing.
“Operationally, this isn’t really going as effectively as we’d like,” he said. “Vaccine supply is limited, and there’s a need to accelerate that supply,” he said…
“We actually want to vaccinate geographic areas where we can’t function because of the insecurity. Unfortunately, there’s going to be a six to 12-month lag before there’s adequate vaccine supply, so we do project that we are going to run out of vaccine,” Redfield said…